nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—Loperamide—POMC—polycystic ovary syndrome	0.011	0.263	CrCbGaD
Diphenidol—Clotrimazole—CYP17A1—polycystic ovary syndrome	0.00797	0.191	CrCbGaD
Diphenidol—Clotrimazole—CYP11A1—polycystic ovary syndrome	0.00784	0.188	CrCbGaD
Diphenidol—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00443	0.106	CrCbGaD
Diphenidol—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.00405	0.0973	CrCbGaD
Diphenidol—Clotrimazole—CYP19A1—polycystic ovary syndrome	0.00405	0.0973	CrCbGaD
Diphenidol—Methadone—CYP19A1—polycystic ovary syndrome	0.00238	0.057	CrCbGaD
Diphenidol—CHRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000772	0.000805	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00077	0.000803	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000769	0.000803	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NPB—polycystic ovary syndrome	0.000767	0.000801	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000763	0.000796	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000762	0.000795	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00076	0.000793	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00076	0.000793	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000753	0.000786	CbGpPWpGaD
Diphenidol—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000751	0.000783	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000745	0.000778	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000743	0.000775	CbGpPWpGaD
Diphenidol—CHRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000738	0.00077	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000736	0.000768	CbGpPWpGaD
Diphenidol—CHRM3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000735	0.000767	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000728	0.00076	CbGpPWpGaD
Diphenidol—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000728	0.00076	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000726	0.000757	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000719	0.00075	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000715	0.000746	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000712	0.000743	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000705	0.000736	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000701	0.000731	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000699	0.000729	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000696	0.000726	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000696	0.000726	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000694	0.000724	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000693	0.000723	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000692	0.000722	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00069	0.00072	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000687	0.000717	CbGpPWpGaD
Diphenidol—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000684	0.000714	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000684	0.000713	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000682	0.000711	CbGpPWpGaD
Diphenidol—CHRM3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000682	0.000711	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00068	0.000709	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000677	0.000706	CbGpPWpGaD
Diphenidol—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000675	0.000704	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000675	0.000704	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000673	0.000702	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000668	0.000697	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000659	0.000688	CbGpPWpGaD
Diphenidol—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000655	0.000683	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000649	0.000677	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000647	0.000675	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000643	0.00067	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000643	0.00067	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000641	0.000668	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00064	0.000668	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00064	0.000668	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000634	0.000662	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000634	0.000662	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—STAR—polycystic ovary syndrome	0.000629	0.000656	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000619	0.000646	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000617	0.000644	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000611	0.000638	CbGpPWpGaD
Diphenidol—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000605	0.000631	CbGpPWpGaD
Diphenidol—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000603	0.000629	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000601	0.000627	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000599	0.000625	CbGpPWpGaD
Diphenidol—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000597	0.000623	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000593	0.000619	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000583	0.000609	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000582	0.000607	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000576	0.000601	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000568	0.000592	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000566	0.00059	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—HMMR—polycystic ovary syndrome	0.000561	0.000585	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00056	0.000585	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000553	0.000577	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000551	0.000575	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000546	0.00057	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000535	0.000558	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000516	0.000539	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000515	0.000537	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00051	0.000532	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000504	0.000525	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000502	0.000524	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000497	0.000519	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—LHB—polycystic ovary syndrome	0.000488	0.000509	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000477	0.000497	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00047	0.000491	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000469	0.000489	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000464	0.000484	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000462	0.000482	CbGpPWpGaD
Diphenidol—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00046	0.00048	CbGpPWpGaD
Diphenidol—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000459	0.000479	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000457	0.000477	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000456	0.000476	CbGpPWpGaD
Diphenidol—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000455	0.000474	CbGpPWpGaD
Diphenidol—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000453	0.000472	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000451	0.000471	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000442	0.000461	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000441	0.00046	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000436	0.000455	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00043	0.000449	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000429	0.000447	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000425	0.000443	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000425	0.000443	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000419	0.000437	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000418	0.000436	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000417	0.000435	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000415	0.000434	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000414	0.000432	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000414	0.000432	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000413	0.000431	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000411	0.000429	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000411	0.000429	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000409	0.000427	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000409	0.000426	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000408	0.000426	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000404	0.000421	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.0004	0.000417	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000399	0.000416	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000397	0.000414	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000395	0.000412	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000387	0.000404	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000386	0.000403	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000386	0.000403	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000385	0.000402	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000383	0.0004	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000382	0.000399	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000382	0.000399	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000381	0.000398	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000381	0.000398	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000378	0.000395	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000378	0.000395	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000377	0.000394	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000376	0.000393	CbGpPWpGaD
Diphenidol—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000374	0.000391	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000374	0.00039	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000366	0.000382	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000365	0.00038	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000361	0.000377	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000359	0.000375	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000358	0.000374	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000356	0.000372	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000355	0.000371	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000355	0.000371	CbGpPWpGaD
Diphenidol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000355	0.00037	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000355	0.00037	CbGpPWpGaD
Diphenidol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000354	0.000369	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000352	0.000367	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000351	0.000366	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.00035	0.000365	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00035	0.000365	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000346	0.000362	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000333	0.000347	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000332	0.000346	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000328	0.000343	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000328	0.000342	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000327	0.000341	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000324	0.000338	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000314	0.000327	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000313	0.000326	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.00031	0.000323	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000303	0.000316	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000298	0.000311	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000297	0.00031	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000295	0.000307	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000294	0.000307	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000293	0.000306	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000293	0.000305	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000291	0.000303	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00029	0.000302	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.00029	0.000302	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000287	0.000299	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000277	0.000289	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00027	0.000282	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00027	0.000282	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000269	0.000281	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000269	0.000281	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000267	0.000278	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000267	0.000278	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00026	0.000272	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000259	0.000271	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000258	0.000269	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000257	0.000268	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000257	0.000268	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000254	0.000265	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000251	0.000262	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00025	0.000261	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00025	0.000261	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000249	0.00026	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000248	0.000259	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000247	0.000258	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000247	0.000258	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000238	0.000248	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000237	0.000247	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000236	0.000247	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000236	0.000246	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000236	0.000246	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000235	0.000246	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000235	0.000245	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000235	0.000245	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000233	0.000243	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000233	0.000243	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000227	0.000237	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000226	0.000236	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000224	0.000234	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000224	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000223	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000223	0.000233	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000221	0.00023	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000208	0.000217	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000207	0.000216	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000207	0.000216	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000205	0.000214	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000197	0.000206	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000197	0.000205	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000195	0.000203	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000194	0.000202	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000193	0.000202	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000191	0.0002	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	0.000169	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—POMC—polycystic ovary syndrome	0.000166	0.000174	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000166	0.000173	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000166	0.000173	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—INS—polycystic ovary syndrome	0.000165	0.000173	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000164	0.000171	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000162	0.00017	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000162	0.000169	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.00016	0.000167	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000145	0.000151	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000144	0.000151	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000143	0.000149	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.00014	0.000146	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000139	0.000145	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000139	0.000145	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	0.000138	0.000144	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000138	0.000144	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	0.000137	0.000143	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000134	0.00014	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000134	0.00014	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000134	0.00014	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000134	0.00014	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000133	0.000138	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000132	0.000138	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000128	0.000133	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000127	0.000133	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000126	0.000131	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000103	0.000107	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000102	0.000107	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000101	0.000106	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.77e-05	9.15e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.74e-05	9.12e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.66e-05	9.03e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	6.07e-05	6.33e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	6.05e-05	6.31e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	5.99e-05	6.25e-05	CbGpPWpGaD
